Newsroom

News, research and milestones.

Announcements and scientific updates from TechImmune as we advance the first T-cell immunotherapy designed to clear persistent SARS-CoV-2 reservoirs and treat Long COVID, alongside selected research shaping the field.

TechImmune News Company announcements, leadership news and research from TechImmune, Inc.
Leadership08.01.2025
James F. Young, PhD

James F. Young, PhD named Executive Chairman

TechImmune, Inc.
In the News09.08.2025
A research laboratory advancing immunotherapy for Long COVID

COVID expert to chair TechImmune

Orange County Business Journal
Clinical09.08.2025
SARS-CoV-2 virus particles under electron microscopy

TechImmune prepares to begin clinical trials

Orange County Business Journal
Research09.27.2025
Dark-field microscopy of T-cells converging on a virus particle

Insights into persistent SARS-CoV-2 reservoirs in chronic Long COVID

TechImmune Research Review
Policy09.28.2025
The unmet need for a Long COVID therapy

Long COVID named an HHS national priority for 2025-2026

TechImmune, Inc.
Long COVID in the Research Selected peer-reviewed studies and reporting from independent publishers. Links open the original source.
JAMA Network Open Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals May 27, 2026 Fox News · Opinion Dr. Robert Redfield: Innovation will provide solutions to Long COVID, the new chronic disease of our time May 4, 2026 CIDRAP · U. of Minnesota Studies: 1 in 7 US working-age adults report long COVID, with heaviest burden on the poor 2025 ABC News 5 years ago, the WHO declared COVID a pandemic. A look at the disease by the numbers March 11, 2025
Concept preview·by DGB Innovations·independent mockup, not affiliated with or endorsed by TechImmune, Inc.·not the official website